S-1/cpt-11/cetuximab combination therapy in patients with advanced colorectal kras wild cancer: phase 2 trial

ABSTRACT: Interventions: ts-1 cpt-11 cetuximab Primary outcome(s): response rate Study Design: Single arm Non-randomized

DISEASE(S): Advanced Colorectal Kras-wild Cancer

PROVIDER: 2621493 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR